Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for ...

HSBC issued a double downgrade on AMD, lowering its rating on the stock from buy to reduce. HSBC's analysts also lowered their one-year price target on AMD stock from $200 per share to $110 per share.

JPMorgan downgraded the stock this morning. Expectations for Archer seem to have gotten ahead of reality. The company still doesn't have any revenue. Editor's note: This article has been corrected.

AMD stock (NASDAQ:AMD) has seen a meaningful sell-off over the past week, declining by about 11% over the last five trading days. The stock also remains down by about 25% since early 2024.

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Shares of analog chips maker ON Semiconductor (NASDAQ:ON) fell 7.8% in the morning session after Truist analyst downgraded the stock's rating from Buy to Hold and lowered the price target from $85 ...